Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04981509
Title Testing of Bevacizumab, Erlotinib, and Atezolizumab for Advanced-Stage Kidney Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital Midtown RECRUITING Atlanta Georgia 30308 United States Details
Emory University Hospital/Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Emory Saint Joseph's Hospital RECRUITING Atlanta Georgia 30342 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
National Institutes of Health Clinical Center SUSPENDED Bethesda Maryland 20892 United States Details
NCI - Center for Cancer Research RECRUITING Bethesda Maryland 20892 United States Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08903 United States Details
NYU Langone Hospital - Long Island RECRUITING Mineola New York 11501 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone RECRUITING New York New York 10016 United States Details
Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) RECRUITING Pittsburgh Pennsylvania 15232 United States Details
M D Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field